Ascend Advanced Therapies Introduces Enhancers Delivering Up to 3x Increase in AAV Production Yields
Ascend Advanced Therapies has released new data showing that two proprietary manufacturing enhancers deliver a substantial increase in adeno-associated virus (AAV) production yields without affecting product quality. The enhancers were tested across multiple scales in HEK293 cells using both Ascend’s EpyQ®